Clinical Trial Update: Radiolabeled Molecules for Medullary Thyroid Cancer [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating radiolabeled molecules for medullary thyroid cancer, sponsored by Instituto Nacional de Cancer in Brazil.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Medullary Thyroid Cancer

Drugs mentioned

• Radiolabeled Molecules for Medullary Thyroid Cancer

Snippet

Sponsor: Instituto Nacional de Cancer, Brazil | Conditions: Medullary Thyroid Cancer | Phase 4 | Status: UNKNOWN